| UniProt ID | LIPE_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y5X9 | |
| Protein Name | Endothelial lipase | |
| Gene Name | LIPG | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 500 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Has phospholipase and triglyceride lipase activities. Hydrolyzes high density lipoproteins (HDL) more efficiently than other lipoproteins. Binds heparin.. | |
| Protein Sequence | MSNSVPLLCFWSLCYCFAAGSPVPFGPEGRLEDKLHKPKATQTEVKPSVRFNLRTSKDPEHEGCYLSVGHSQPLEDCSFNMTAKTFFIIHGWTMSGIFENWLHKLVSALHTREKDANVVVVDWLPLAHQLYTDAVNNTRVVGHSIARMLDWLQEKDDFSLGNVHLIGYSLGAHVAGYAGNFVKGTVGRITGLDPAGPMFEGADIHKRLSPDDADFVDVLHTYTRSFGLSIGIQMPVGHIDIYPNGGDFQPGCGLNDVLGSIAYGTITEVVKCEHERAVHLFVDSLVNQDKPSFAFQCTDSNRFKKGICLSCRKNRCNSIGYNAKKMRNKRNSKMYLKTRAGMPFRVYHYQMKIHVFSYKNMGEIEPTFYVTLYGTNADSQTLPLEIVERIEQNATNTFLVYTEEDLGDLLKIQLTWEGASQSWYNLWKEFRSYLSQPRNPGRELNIRRIRVKSGETQRKLTFCTEDPENTSISPGRELWFRKCRDGWRMKNETSPTVELP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSNSVPLLC ------CCCCHHHHH | 37.50 | 28348404 | |
| 4 | Phosphorylation | ----MSNSVPLLCFW ----CCCCHHHHHHH | 20.15 | 28348404 | |
| 12 | Phosphorylation | VPLLCFWSLCYCFAA HHHHHHHHHHHHHHC | 6.57 | 28348404 | |
| 41 | O-linked_Glycosylation | KLHKPKATQTEVKPS CCCCCCCCCCCCCCE | 41.99 | OGP | |
| 48 | O-linked_Glycosylation | TQTEVKPSVRFNLRT CCCCCCCEEEEECCC | 21.87 | OGP | |
| 80 | N-linked_Glycosylation | PLEDCSFNMTAKTFF CCCCCCEECCEEEEE | 15.59 | UniProtKB CARBOHYD | |
| 136 | N-linked_Glycosylation | QLYTDAVNNTRVVGH HHHHHHCCCCEECHH | 45.97 | UniProtKB CARBOHYD | |
| 185 | Phosphorylation | AGNFVKGTVGRITGL CCCCCCCCCCEECCC | 17.67 | - | |
| 190 | Phosphorylation | KGTVGRITGLDPAGP CCCCCEECCCCCCCC | 30.26 | - | |
| 324 | Sumoylation | NSIGYNAKKMRNKRN CCCCCCHHHHHCCCC | 43.39 | - | |
| 325 | Sumoylation | SIGYNAKKMRNKRNS CCCCCHHHHHCCCCC | 40.45 | - | |
| 332 | Phosphorylation | KMRNKRNSKMYLKTR HHHCCCCCCEEEEEC | 23.88 | 23911959 | |
| 338 | Phosphorylation | NSKMYLKTRAGMPFR CCCEEEEECCCCCEE | 24.13 | 23911959 | |
| 393 | N-linked_Glycosylation | IVERIEQNATNTFLV HHHHHHHHCCCEEEE | 35.62 | 16335952 | |
| 435 | Phosphorylation | KEFRSYLSQPRNPGR HHHHHHHCCCCCCCC | 29.88 | 24719451 | |
| 469 | N-linked_Glycosylation | FCTEDPENTSISPGR EECCCCCCCCCCCCC | 44.51 | UniProtKB CARBOHYD | |
| 491 | N-linked_Glycosylation | RDGWRMKNETSPTVE CCCCEECCCCCCCCC | 48.73 | UniProtKB CARBOHYD | |
| 496 | O-linked_Glycosylation | MKNETSPTVELP--- ECCCCCCCCCCC--- | 26.78 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LIPE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LIPE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LIPE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LIPE_HUMAN | LIPG | physical | 19567873 | |
| LIPE_MOUSE | Lipg | physical | 15117821 | |
| DJC13_HUMAN | DNAJC13 | physical | 28514442 | |
| TMED4_HUMAN | TMED4 | physical | 28514442 | |
| TBB1_HUMAN | TUBB1 | physical | 28514442 | |
| TMED9_HUMAN | TMED9 | physical | 28514442 | |
| TMED5_HUMAN | TMED5 | physical | 28514442 | |
| TRM1_HUMAN | TRMT1 | physical | 28514442 | |
| PLSI_HUMAN | PLS1 | physical | 28514442 | |
| PTPRS_HUMAN | PTPRS | physical | 28514442 | |
| NRP1_HUMAN | NRP1 | physical | 28514442 | |
| TMEDA_HUMAN | TMED10 | physical | 28514442 | |
| TMED2_HUMAN | TMED2 | physical | 28514442 | |
| CALX_HUMAN | CANX | physical | 28514442 | |
| ITIH2_HUMAN | ITIH2 | physical | 28514442 | |
| SDC2_HUMAN | SDC2 | physical | 28514442 | |
| 1C07_HUMAN | HLA-C | physical | 28514442 | |
| MK14_HUMAN | MAPK14 | physical | 28514442 | |
| ARL8A_HUMAN | ARL8A | physical | 28514442 | |
| ABHEA_HUMAN | ABHD14A | physical | 28514442 | |
| GPC3_HUMAN | GPC3 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-393, AND MASSSPECTROMETRY. | |